Everything you ever wanted to know about hair bonds and bond-building products, including how Olaplex, K18, and other ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

The two men, who’d each been diagnosed with schizophrenia in their 20s and ended up in Alaska’s correctional system, should ...

About REFOCUS-ALZ REFOCUS-ALZ (NCT05026177) is a Phase 3 trial designed as a multi-center, double-blinded, placebo-controlled, randomized parallel group study ... function from baseline to the end of ...

In the UK, you set up the Cancer Vaccine Launch Pad at the end of 2022 to fast-track cancer ... patients with access to personalized cancer treatments by 2030, and a 10-year investment with ...

The data readout includes safety data from two Phase 3 pediatric and adolescent studies - a fixed dose study and a dose optimization study - as well as a food effect study with healthy adults, using a ...

PEMGARDA (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 ...

Its first clinical application focuses on a new Parkinson’s treatment using patient-specific ... through software and AI from beginning to end for the entire duration of the process,” she ...

Pain in your arms is a common symptom with many different causes, from arthritis and overuse injuries like tendonitis to a heart attack.

It's a problem growing in parallel to the chemicals' prevalence on Earth ... Farmers in North Carolina and elsewhere have been using the waste as a field treatment for decades as a useful end for the ...